Report : Europe Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Tabletop Type and Handheld Type) and End User (Hospitals, Clinics, and Others)
The hospitals segment by end user is estimated to lead the market growth during the forecast period.
According to a new market research study of “Europe Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, End User and Country.” The Europe optical coherence tomography angiography equipment market is expected to reach US$ 360.54 million by 2028 from US$ 23.74 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights trends prevailing in the Europe optical coherence tomography angiography equipment market and the factors driving market along with those that act as hindrances.
Glaucoma is a leading cause of blindness among people aged more than 60. The other causes of blindness include age-related macular degeneration, retinal detachment, and diabetic retinopathy, contributing to over 6 million blind adults aged 50 and older. A rise in the geriatric population in developed countries in Europe, such as the UK, is driven by the modernization of healthcare facilities and improvements in healthcare services, which has boosted the life expectancy in these countries. According to data by the World Health Organization (WHO) in February 2018, the geriatric population is estimated to grow from 12% in 2015 to 22% by 2050. With the increasing age, the incidence of various eye-related disorders has increased, resulting in age-related macular degeneration (AMD).
According to the statistics from the United Nations (UN) Global Population Prospects for 2019, the world population is projected to grow by 2 billion over the next 30 years, and the global geriatric population is also rising. As per the National Institutes of Health, the number of people over 65 was ~703 million in 2019, accounting for ~9% of the global population. AMD is the leading cause of permanent impairment of fine or close-up vision among people aged 65 and older. As per the “Causes of blindness and vision impairment in 2020” study, with reference to the individual causes of global visual impairment in 2020, ~206 million adults aged 50 and above were living with moderate and severe vision impairment (MSVI) due to AMD (6.2 million cases). ~33.6 million adults aged over 50 are blind, and glaucoma (3.6 million cases), AMD (1.8 million cases), and diabetic retinopathy are among the major causes of blindness among them. Thus, the rise in prevalence of retinal diseases among the growing the aging population driving the demand for optical coherence tomography angiography equipment.
The Europe optical coherence tomography angiography equipment market, based on type, has been bifurcated into handheld type and tabletop type. The Europe optical coherence tomography angiography equipment market, based on end user is segmented into hospitals, clinics, and others. Geographically, the Europe optical coherence tomography angiography equipment market is divided into Germany, Italy, Spain, France, UK and Rest of Europe.
NIDEK CO., LTD; Carl Zeiss AG; Canon Inc.; OPTOPOL Technology Sp. z o.o; Michelson Diagnostics Ltd.; SANTEC CORPORATION; Alcon Inc.; Topcon Corporation and Heidelberg Engineering GmbH are among the leading companies operating in the Europe optical coherence tomography angiography equipment market.
Contact Person: Sameer Joshi
Email Id: email@example.com